Guidance and quality standards In consultation
Showing 1 to 3 of 3
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| 12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280] | Draft guidance | Technology appraisal guidance | |
| Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (Review of TA869) [ID6333] | Draft guidance | Technology appraisal guidance | |
| Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments [ID4026] | Draft guidance | Technology appraisal guidance |